PATENT CLAIM ANALYSIS

Application Number: 15560145
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "460000"]

Abstract:
The present invention relates to, in part, methods for the treatment of methanogen-associated disorders such as, for example, Irritable Bowel Syndrome (IBS) using at least one anti-methanogenic lovastatin analog or derivative. In addition, modified-release formulations comprising at least one anti-methanogenic lovastatin analog or derivative are provided which release the anti-methanogenic lovastatin analog or derivative in the gastrointestinal tract.

Claim (Index 75):
The method of  claim 74 , wherein the one or more regions of the intestinal tract are selected from the duodenum, the jejunum, the ileum, the ileocecal junction, the cecum, the ascending, transverse, descending or sigmoid portions of the colon, and the rectum.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 91.0
- Lexical Diversity: 1.48889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15940063', '14826115', '15810891', '15656758', '15043223']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7284679050009666
- 35 USC 102 Novelty (BERT): 0.5348949762836915
- Combined Prediction Score: 0.7091106121292391
- Mean Citation Score: 239.944296
- Max Citation Score: 335.23923
- Similarity Product: 155.78298711876508

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test